WO2008133982A3 - Adhesive patch with aversive agent - Google Patents

Adhesive patch with aversive agent Download PDF

Info

Publication number
WO2008133982A3
WO2008133982A3 PCT/US2008/005339 US2008005339W WO2008133982A3 WO 2008133982 A3 WO2008133982 A3 WO 2008133982A3 US 2008005339 W US2008005339 W US 2008005339W WO 2008133982 A3 WO2008133982 A3 WO 2008133982A3
Authority
WO
WIPO (PCT)
Prior art keywords
adhesive patch
aversive agent
patch
medicament
adhesive
Prior art date
Application number
PCT/US2008/005339
Other languages
French (fr)
Other versions
WO2008133982A2 (en
Inventor
David Rolf
Original Assignee
Lectec Corp
David Rolf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lectec Corp, David Rolf filed Critical Lectec Corp
Publication of WO2008133982A2 publication Critical patent/WO2008133982A2/en
Publication of WO2008133982A3 publication Critical patent/WO2008133982A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01D—MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
    • G01D11/00—Component parts of measuring arrangements not specially adapted for a specific variable
    • G01D11/28—Structurally-combined illuminating devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Abstract

The disclosed subject matter provides an adhesive patch that includes a medicament and an aversive agent. The adhesive patch may be a transdermal patch, suitable for systemically delivering a medicament; or may be a topical patch, suitable for locally delivering a medicament to the surface of the skin.
PCT/US2008/005339 2007-04-27 2008-04-25 Adhesive patch with aversive agent WO2008133982A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92648307P 2007-04-27 2007-04-27
US60/926,483 2007-04-27

Publications (2)

Publication Number Publication Date
WO2008133982A2 WO2008133982A2 (en) 2008-11-06
WO2008133982A3 true WO2008133982A3 (en) 2009-05-07

Family

ID=39926273

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/005339 WO2008133982A2 (en) 2007-04-27 2008-04-25 Adhesive patch with aversive agent

Country Status (1)

Country Link
WO (1) WO2008133982A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11844763B2 (en) 2014-04-17 2023-12-19 Avenir Wellness Solutions, Inc. Pharmaceutical composition and method of manufacturing

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008535862A (en) 2005-04-08 2008-09-04 キメリクス，インコーポレイテッド Compounds, compositions and methods for the treatment of poxvirus infections
EP2522343A1 (en) 2006-03-28 2012-11-14 Javelin Pharmaceuticals, Inc. Formulations of Low Dose Diclofenac and Beta-Cyclodextrin
AU2009206673B2 (en) 2008-01-25 2015-04-23 Chimerix, Inc. Methods of treating viral infections
WO2010135131A2 (en) * 2009-05-22 2010-11-25 Wyeth Llc Single-use, disposable strip for application of topical compositions
WO2011011519A1 (en) 2009-07-21 2011-01-27 Chimerix, Inc. Compounds, compositions and methods for treating ocular conditions
US9168232B2 (en) 2009-09-07 2015-10-27 Nipro Patch Co., Ltd. Transdermally absorbable preparation
GB0917086D0 (en) * 2009-09-29 2009-11-11 Union Of Agricultural Cooperat Compositon of botanical extracts and their use
EP2534150B1 (en) 2010-02-12 2017-04-05 Chimerix, Inc. Methods of treating viral infection
US20110293681A1 (en) * 2010-02-26 2011-12-01 Lectec Corporation Hand sanitizing patch having an integrally bonded antimicrobial
WO2011139709A2 (en) 2010-04-26 2011-11-10 Chimerix, Inc. Methods of treating retroviral infections and related dosage regimes
NZ587634A (en) * 2010-08-27 2013-10-25 Rato Health Ltd Transdermal Patch
WO2013027840A1 (en) * 2011-08-25 2013-02-28 ニプロパッチ株式会社 Hydrous adhesive skin patch
EP2804897B1 (en) * 2012-01-20 2016-07-13 Altria Client Services LLC Oral product
CN102754907B (en) 2012-01-20 2015-06-24 奥驰亚客户服务公司 Oral product
CN103040089B (en) * 2012-01-20 2016-08-17 奥驰亚客户服务公司 Oral product
US9854831B2 (en) 2012-01-20 2018-01-02 Altria Client Services Llc Oral product
CN103040090B (en) 2012-01-20 2016-03-30 奥驰亚客户服务公司 Remove the oral product of tobacco
CN102754908B (en) 2012-01-20 2015-06-10 奥驰亚客户服务公司 Oral tobacco product
CN103039688B (en) 2012-01-20 2016-01-06 奥驰亚客户服务公司 Oral product
FR2992560B1 (en) * 2012-07-02 2015-10-02 Oreal USE AS ANTIPELLICULAR AGENT OF AN ESSENTIAL OIL OF ORIGAN MARJOLAINE, PROCESSING PROCESS AND COMPOSITION COMPRISING SAME
DE102012212281B3 (en) 2012-07-13 2013-10-31 Schülke & Mayr GmbH Mixture of natural or nature-identical alcohols with improved effectiveness
CN103230442B (en) * 2013-04-25 2015-01-07 东阳市人民医院 Xanthium sibiricum Patr.ex Widd external medical composition for treating swelling and preparation method thereof
MX2013005405A (en) * 2013-05-14 2014-11-20 Abert Pla Andreu Composition based on natural oils to be applied to toilet paper, which assists with sanitisation following defecation, with an astringent, analgesic, humectant, disinfectant and antiseptic effect in people with or without hemorrhoids, method for the production thereof, and use thereof.
WO2015061847A1 (en) * 2013-10-28 2015-05-07 Atp Institute Pty Ltd Pain relief formulation and method of treatment
CN115444659A (en) * 2014-01-22 2022-12-09 4P治疗公司 Abuse and misuse deterrent transdermal system
US9186386B2 (en) 2014-04-17 2015-11-17 Gary J. Speier Pharmaceutical composition and method of manufacturing
CN103976988A (en) * 2014-05-26 2014-08-13 中国药科大学 Application of L-menthone in preparing anti-depression medicament
DK3010511T3 (en) 2014-09-12 2018-03-05 Antibiotx As ANTIBACTERIAL USE OF HALOGENERED SALICYLANILIDES
CN104664376A (en) * 2015-02-11 2015-06-03 化州市佰亿化橘红科技有限公司 Pine needle-flower-fruit composition
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
FR3037500A1 (en) * 2015-06-19 2016-12-23 Kala Karite CHEMICAL COMPOSITION FOR DERMITE
AU2017229125B2 (en) 2016-03-08 2021-07-29 Living Proof, Inc. Long lasting cosmetic compositions
CN106085661A (en) * 2016-06-16 2016-11-09 广西南宁诺尔网络通讯技术有限公司 A kind of mosquito proof handmade soap and preparation method thereof
US20190374552A1 (en) * 2016-11-02 2019-12-12 George Edward Hoag Multifunctional formulations and methods to control dermatitis and pruritus
CN106692112B (en) * 2016-12-06 2019-07-16 湘潭大学 A kind of strychnia patch for treating local soft tissue inflammatory pain
KR101880442B1 (en) * 2017-02-02 2018-07-23 대구한의대학교산학협력단 Patch composition for lowering blood pressure
DE102017110405A1 (en) * 2017-05-12 2018-11-15 Msf Medizinische Sportwerke Frankfurt Gmbh Oily plant extracts containing elements and plasters containing such active ingredient-containing elements
CN107335058B (en) * 2017-07-31 2021-01-08 暨南大学 New application of 2, 6-disubstituted pyridine-4-thiocarboxamide
CN111133023B (en) 2017-09-13 2022-10-18 生活实验公司 Long-lasting cosmetic composition
CA3074845A1 (en) 2017-09-13 2019-03-21 Living Proof, Inc. Color protectant compositions
CN107916186A (en) * 2017-11-16 2018-04-17 东兴市良佳优农林科技有限公司 Essential oil soap of extract containing lemon grass and preparation method thereof
CN108403573A (en) * 2018-06-07 2018-08-17 广州宫森生物科技有限公司 A kind of preparation method of acne removal stock liquid
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide
US20200338016A1 (en) * 2019-04-26 2020-10-29 Mark Edward Fenzl Combination broad-spectrum antibiotic preparations for drug-resistant pathogens
US20210000754A1 (en) * 2019-07-02 2021-01-07 Clifford T. Rowley Transdermal patch providing improved permeability and composition
US20210059955A1 (en) * 2019-08-26 2021-03-04 RL Patents, LLC Systems and methods for decrystallization of uric acid
CN111187367B (en) * 2020-01-07 2022-02-25 江苏省农业科学院 Urea formaldehyde modified sodium alginate copolymer and application thereof
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
CN112646558B (en) * 2020-12-18 2022-08-16 成都劳恩普斯科技有限公司 Ecological safety sterilization corrosion inhibitor special for shale gas pipeline and preparation method thereof
CN114767871B (en) * 2022-04-19 2023-04-07 中国工程物理研究院机械制造工艺研究所 Mesoporous silicon drug-loaded system, preparation method thereof and mesoporous silicon drug-loaded system

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001068138A2 (en) * 2000-03-10 2001-09-20 Epicept, Inc. Intradermal-penetration agents for topical local anesthetic administration
US20040109886A1 (en) * 2002-08-27 2004-06-10 Larry Rigby Methods and apparatus for transdermal delivery of abusable drugs with a deterrent agent
WO2004062600A2 (en) * 2003-01-08 2004-07-29 Lectec Corporation Antiviral patch
US20040228802A1 (en) * 2003-05-12 2004-11-18 Rong-Kun Chang Drug formulations having reduced abuse potential

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001068138A2 (en) * 2000-03-10 2001-09-20 Epicept, Inc. Intradermal-penetration agents for topical local anesthetic administration
US20040109886A1 (en) * 2002-08-27 2004-06-10 Larry Rigby Methods and apparatus for transdermal delivery of abusable drugs with a deterrent agent
WO2004062600A2 (en) * 2003-01-08 2004-07-29 Lectec Corporation Antiviral patch
US20040228802A1 (en) * 2003-05-12 2004-11-18 Rong-Kun Chang Drug formulations having reduced abuse potential

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11844763B2 (en) 2014-04-17 2023-12-19 Avenir Wellness Solutions, Inc. Pharmaceutical composition and method of manufacturing

Also Published As

Publication number Publication date
WO2008133982A2 (en) 2008-11-06

Similar Documents

Publication Publication Date Title
WO2008133982A3 (en) Adhesive patch with aversive agent
IN2012DN03451A (en)
EP2177217A4 (en) Composition comprising rotigotine, its use and transdermal patch comprising the composition
WO2007120747A3 (en) Transdermal methods and systems for the delivery of anti-migraine compounds
WO2009089494A3 (en) Pharmaceutical compositions
WO2009097508A3 (en) Methods and compositions for wound healing
WO2008057780A3 (en) Transdermal delivery of ketoprofen polar derivatives
WO2012034079A3 (en) Macrolide dosage forms
WO2009031068A3 (en) Disposable wearable absorbent articles with anchoring subsystems
WO2009031069A3 (en) Disposable wearable absorbent articles with anchoring subsystems
WO2009031070A3 (en) Disposable wearable absorbent articles with anchoring subsystems
EP1995282A4 (en) Microparticle-containing viscoelastic layer, and pressure-sensitive adhesive tape or sheet
WO2008090555A3 (en) Medical devices having a matrix adhered thereof
WO2011076621A3 (en) Transdermal therapeutic system for administering rivastigmine or derivatives thereof
WO2007035942A3 (en) Transdermal risperidone delivery system
EP2267090B8 (en) Pressure-sensitive adhesive film and back-grinding method using the same
PT2168608E (en) Pressure-sensitive adhesive tape or sheet for application to skin, and process for producing the same
EP1741448A4 (en) Crosslinkable pressure-sensitive adhesive for the skin
WO2011088333A3 (en) Solid-forming local anesthetic formulations for pain control
WO2011088072A3 (en) Dermal delivery device
WO2011029948A3 (en) Transdermal therapeutic system for administering fentanyl or an analogue thereof
WO2007084753A3 (en) Skin cleansing article
WO2009085890A3 (en) Medical device for skin with ultra-hydrophilic pressure-sensitive adhesive
WO2009106831A3 (en) Pharmaceutical composition comprising naltrexone
WO2008104720A3 (en) Patch for cutaneous application

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08743286

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08743286

Country of ref document: EP

Kind code of ref document: A2